| Medicare Noridian | Billing and Coding: MolDX: Prometheus– IBD sgi Diagnostic– Policy (57516) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Oncotype DX– Breast Cancer for DCIS (Genomic Health–) (57619) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Pigmented Lesion Assay (58052) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer (58181) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (58183) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (58679) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (58973) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (58996) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules (59509) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms (59835) | 2026-01-26 |